Invitris closes major deal in the European Market
We are thrilled to announce a significant milestone for Invitris—a [...]
Celebrating milestones: a remarkable year for Xiretsa
2024 has been a transformative year for Xiretsa, filled with [...]
Call for Submissions: Advances in Bacteriophage Research and Development with Therapeutic Applications
INCATE is pleased to invite researchers, clinicians, and industry experts [...]
Kinzbio: forging ahead in Phage-Based precision antimicrobials
Kinzbio’s mission is to harness the power of phages—nature's precision [...]
BamA Inhibitor Project Secures €180k DATIpilot Grant
The BamA Inhibitor project (Justus-Liebig-University Giessen) has been awarded a [...]
Shionogi and INCATE renew partnership to continue supporting innovators fighting antimicrobial resistance
November 5th, 2024 – INCATE (the INCubator for Antibacterial Therapies [...]
Great news for the hemolysin inhibitor program!
© Marek Kruszewski Researchers from the Helmholtz Centre [...]
“Surviving Superbugs – A Dance To Resist”
credits: Interfinity On April 9th, 2025, 20:30, at [...]
Puray and Munich University of Applied Sciences Secure €300k grant for Light-Based Disinfection Technology
Puray, together with Munich University of Applied Sciences, has been [...]
PHIOGEN: exciting business updates and new opportunities
Photo credits: Phiogen PHIOGEN, a Texas-based venture developing off-the-shelf [...]
